Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Recent patents describe possible new treatment options for diabetes

May 23, 2007

Chloroquine to be evaluated for the treatment of metabolic syndrome / News in Context

May 23, 2007

TRO-19622 begins phase II trial in painful diabetic neuropathy

May 22, 2007

Approvable letter for Mircera

May 21, 2007

ProtoKinetix's AAGP shows promise in preclinical studies for diabetes

May 21, 2007

Obecure evaluates OBE-101's ability to reduce caloric intake in phase II

May 21, 2007

Genzyme reports encouraging results in Gaucher disease study

May 21, 2007

Oxygent enters phase II for patients undergoing CABG surgery

May 21, 2007

Tsumura discontinues development of TU-025 in U.S.

May 18, 2007

Telomerase activator shows beneficial effects on human aging

May 18, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...